Also trades as: ITRMF (OTC) · $vol 0M
ITRM NASDAQ
Iterum Therapeutics plc
1W: -6.4%
1M: -79.9%
3M: -89.3%
YTD: -89.3%
1Y: -97.2%
3Y: -96.5%
5Y: -99.8%
$0.03
Last traded 2026-04-06 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Balance Sheet Trends
Total Assets
$45M
+69.8% ▲
5Y CAGR: +11.6%
Total Liabilities
$49M
+49.0% ▲
5Y CAGR: -1.3%
Shareholders Equity
-$4M
+36.3% ▲
Cash & Investments
$24M
+0.8% ▲
5Y CAGR: +37.9%
Total Debt
$46M
+140.2% ▲
5Y CAGR: +17.0%
Net Debt
$21M
+66.2% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $15M | $27M | $21M | $6M | $24M |
| Short-Term Investments | $0 | $54M | $40M | $18M | $0 |
| Cash & ST Investments | $15M | $81M | $61M | $24M | $24M |
| Net Receivables | $865K | $1M | $513K | $233K | $66K |
| Inventory | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $5M | $37K | $35K | $0 | $65K |
| Total Current Assets | $21M | $83M | $62M | $26M | $25M |
| Property, Plant & Equip. | $6M | $4M | $2M | $600K | $23K |
| Goodwill & Intangibles | $0 | $3M | $2M | $0 | $20M |
| Long-Term Investments | $248K | $64K | $34K | $0 | $0 |
| Other Non-Current Assets | $5M | $912K | $797K | $63K | $39K |
| Total Non-Current Assets | $11M | $8M | $4M | $663K | $20M |
| Total Assets | $33M | $92M | $67M | $26M | $45M |
| — Liabilities — | |||||
| Accounts Payable | $816K | $878K | $3M | $5M | $251K |
| Short-Term Debt | $7M | $2M | $332K | $0 | $14M |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $33M | $9M | $4M | $761K | $240K |
| Total Current Liabilities | $42M | $13M | $9M | $14M | $18M |
| Long-Term Debt | $36M | $25M | $28M | $19M | $31M |
| Other Non-Current Liab. | $630K | $0 | $0 | $188K | $0 |
| Total Non-Current Liabilities | $42M | $28M | $30M | $19M | $31M |
| Total Liabilities | $83M | $41M | $39M | $33M | $49M |
| — Equity — | |||||
| Common Stock | $494K | $2M | $126K | $135K | $315K |
| Retained Earnings | -$287M | -$378M | -$423M | -$461M | -$486M |
| Accumulated OCI | $0 | $0 | -$350K | $1K | $0 |
| Total Stockholders Equity | -$51M | $50M | $28M | -$6M | -$4M |
| Total Liabilities & Equity | $33M | $92M | $67M | $26M | $45M |
| — Key Metrics — | |||||
| Total Debt | $48M | $30M | $30M | $19M | $46M |
| Net Debt | $34M | $3M | $9M | $13M | $21M |
| Total Investments | $248K | $54M | $40M | $18M | $0 |